LAKE FOREST, Ill.–(BUSINESS WIRE)–
Akorn, Inc. (NASDAQ: AKRX) today announced that the U.S. Food and Drug Administration has granted approval for Akorn
s Abbreviated New Drug Application (ANDA) for Adenosine Injection USP, 3 mg/mL.
Adenosine Injection is indicated for supraventricular tachycardia in cardiac patients. Annual sales for Adenosine Injection were approximately $22 million in 2007, according to IMS sales data.
Arthur S. Przybyl, Read the rest of this entry »
Published: November 23, 2008
For 10 years, the landmark Master Settlement Agreement has been dogged by high expectations.
The deal between the top U.S. tobacco manufacturers, including R.J. Reynolds Tobacco Co., and 46 state attorneys general changed an industry when it was signed 10 years ago today.
The states, including North Carolina, agreed to drop their lawsuits against the industry for a $206 billion payout over 25 years, primarily to Read the rest of this entry »
Diane Sutter, president and CEO of MyTV New England pointed out an example of a TV converter box at the Derry station last week. Her station, a MyNetworkTV affiliate, will be the first in the Boston and Manchester market to turn off its analog signal and transmit only in digital, a transition that will take effect Dec. 1.
Charitable requests up, donations down
SNHU, FPC win soccer quarterfinals
Read these stories in today’s Union Leader. Pick Read the rest of this entry »
Shares of
rose Wednesday after the Food and Drug Administration announced a meeting to review the company’s treatment for the inflammatory disorder gout.
The agency’s panel of outside experts will meet March 5 to review the safety and effectiveness of the drug Puricase, known generically as pegloticase. FDA is not required to follow the panel’s advice, though it often does.
The East Brunswick, N.J.-based company’s stock rose 22 cents, or 3.7 Read the rest of this entry »
Feb. 9 (Bloomberg) — Republican Senators are questioning
whether President
’s stimulus bill contains the
right mix of tax breaks and cash infusions to jump-start the
economy.
Tragically, no one from either party is objecting to the
health provisions slipped in without discussion. These
provisions reflect the handiwork of
, until recently
the nominee to head the Health and Human Services Department.
Senators should read these provisions Read the rest of this entry »
San Jose city officials, facing a $65 million shortfall, are penny-pinching everywhere they can. Or are they? Yesterday, the council signed off on cutting 52 positions. Another 18 employees could lose their jobs in March. Meanwhile, Councilwoman
shelled out more than $6,000 to buy new furniture for her City Hall office. Pyle defends her purchase (which obviously isn’t going to save even one part-time job) saying she cut costs elsewhere and saved Read the rest of this entry »
The statistics are sobering: Heart disease is the number-one killer of women in the United States. And an estimated 8 million women have it. What’s more, a new study shows that in recent years the overall heart disease risk for Americans — especially women — hasn’t continued the healthy downward trend it showed in previous decades.
Ready for some good news? You can do more to prevent heart disease than almost any other serious condition. Start Read the rest of this entry »
Cosmetic drugmaker Allergan Inc. said Friday its eyelash treatment Latisse received Food and Drug Administration approval.
The drug treats the condition hypotrichosis of the eyelashes and is applied once-daily to increase thickness and fullness, the company said. The treatment has full results within 16 weeks, it said.
“Latisse fulfills a significant and previously unmet need in the medical aesthetic marketplace with a product approved by the Read the rest of this entry »
Copyright 2009, Arkansas Democrat-Gazette, Inc.
All rights reserved.
This document may not be reprinted without the express written permission of Arkansas Democrat-Gazette, Inc.
Material from the Associated Press is Copyright 2009, Associated Press and may not be published, broadcast, rewritten, or redistributed. Associated Press text, photo, graphic, audio and/or video material shall not be published, broadcast, rewritten for broadcast or Read the rest of this entry »
NEW DELHI: The Union health ministry
has come to the defence of Ranbaxy, alleging that vested interests were behind
the US ban on 30 drugs of the Indian pharma major. The US Food and Drug
Administration (FDA) was being pressurised by political and pharma lobbies to
act against Ranbaxy, a top official of the ministry said.
“The
FDA never had problems with the same drugs earlier. The moment the House (US
Congress) committee on trade, commerce Read the rest of this entry »